Review of Quality Assurance in the Province's Cancer Drug Supply Chain

Wednesday, August 7, 2013

The Ontario government is taking action to make the province's cancer system safer for patients, following the release of Dr. Jake Thiessen's review into Ontario's cancer drug supply chain. In April, Thiessen, the Founding Director of the University of Waterloo’s School of Pharmacy, was appointed to lead an independent review of the recent discovery of under-dosing of chemotherapy drugs at five hospitals in Ontario and New Brunswick.

Dr. Thiessen's report entitled, "A Review of the Oncology Under-Dosing Incident" was released today to the Minister of Health and Long-Term Care, and includes recommendations that would prevent a similar incident from occurring again. The recommendations build on actions Ontario already has taken to safeguard the system as soon as the under-dosage was reported.

Click here for more information and to view the complete report.
Source: Ontario Ministry of Health


media inquiries

Sara Wilson
Publicity and Promotions Specialist
South West Regional Cancer Program
519-685-8500 ext. 71826